| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2006 | CA2311344C 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/07/2006 | CA2268484C Cyclobutyl-aryloxyarylsulfonylamino hydroxamic acid derivatives |
| 02/07/2006 | CA2262454C Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha. |
| 02/07/2006 | CA2221075C Use of aminoalcohol derivatives in the treatment of liver disease |
| 02/07/2006 | CA2216288C Uracilic hydroquinone derivatives as type iv allergy inhibitors |
| 02/07/2006 | CA2209848C Pharmaceutical and dietary composition containing sodium, potassium, magnesium and calcium ions and enzyme activators |
| 02/07/2006 | CA2200433C Phenyloxazolidinone antimicrobials |
| 02/07/2006 | CA2173158C Anthracycline disaccharides, process for their preparation, and pharmaceutical compositions containing them |
| 02/07/2006 | CA2143853C 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones with antitumour activity |
| 02/07/2006 | CA2137764C Pharmaceutical compositions comprising solutions or dispersions of a staurosporine active ingredient in a saturated polyalkylene glycol glyceride |
| 02/07/2006 | CA2135639C Controlled release preparation containing a salt of morphine |
| 02/07/2006 | CA2119783C Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 02/07/2006 | CA2026147C Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 02/05/2006 | WO2007030089A1 Tricyclic delta- opioid modulators |
| 02/05/2006 | CA2574768A1 Tricyclic delta-opioid modulators |
| 02/02/2006 | WO2006012640A2 Method of administration of dopamine receptor agonists |
| 02/02/2006 | WO2006012639A2 Method of diagnosing, monitoring and treating pulmonary diseases |
| 02/02/2006 | WO2006012603A2 Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases |
| 02/02/2006 | WO2006012577A2 Quinazolinone derivatives useful for the regulation of glucose homeostasis and food intake |
| 02/02/2006 | WO2006012563A2 Method for the treatment and diagnosis of certain psychiatric disorders related to the menstrual cycle |
| 02/02/2006 | WO2006012521A2 Treatment for ocular disease |
| 02/02/2006 | WO2006012502A2 Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| 02/02/2006 | WO2006012492A2 Compositions and methods for viscosupplementation |
| 02/02/2006 | WO2006012476A2 Method for treating nervous system disorders and conditions |
| 02/02/2006 | WO2006012474A1 Method for treating nervous system disorders and conditions |
| 02/02/2006 | WO2006012473A1 Dynamic knowledge-based networking system and method |
| 02/02/2006 | WO2006012440A2 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives |
| 02/02/2006 | WO2006012438A2 Compositions and methods for treatment and prevention of insulin resistance |
| 02/02/2006 | WO2006012422A1 Imidazopyrazine as tyrosine kinase inhibitors |
| 02/02/2006 | WO2006012402A1 Use of adiponectin to diagnose and treat malignancy |
| 02/02/2006 | WO2006012395A2 Peptidase inhibitors |
| 02/02/2006 | WO2006012374A1 Substituted aryl-amine derivatives and methods of use |
| 02/02/2006 | WO2006012310A2 Carbazole derivatives for treating polycystic kidney disease |
| 02/02/2006 | WO2006012256A2 Fkbp binding composition and pharmaceutical use thereof |
| 02/02/2006 | WO2006012237A2 Aripiprazole crystaline forms and associated methods |
| 02/02/2006 | WO2006012227A2 Amido compounds and their use as pharmaceuticals |
| 02/02/2006 | WO2006012226A2 N-substituted piperidines and their use as pharmaceuticals |
| 02/02/2006 | WO2006012204A2 Method for treatment of inflammatory disorders using triptolide compounds |
| 02/02/2006 | WO2006012173A1 Amido compounds and their use as pharmaceuticals |
| 02/02/2006 | WO2006012155A1 Xanthan gum viscoelastic composition for viscosurgery |
| 02/02/2006 | WO2006012146A2 Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same |
| 02/02/2006 | WO2006012145A1 Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| 02/02/2006 | WO2006012140A1 Carboranylporphyrins and uses thereof |
| 02/02/2006 | WO2006011915A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 02/02/2006 | WO2006011670A1 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE |
| 02/02/2006 | WO2006011669A1 Novel cinnamic acid related compounds |
| 02/02/2006 | WO2006011638A1 Film coated tablet having plural coats |
| 02/02/2006 | WO2006011637A1 Film-coated tablet |
| 02/02/2006 | WO2006011592A1 Composition for capsule film, capsule film, and capsule made with the same |
| 02/02/2006 | WO2006011588A1 Medicinal composition containing diabetes remedy |
| 02/02/2006 | WO2006011561A1 Oligosaccharide derivative having heterocyclic ring |
| 02/02/2006 | WO2006011502A1 Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | WO2006011495A1 Remedy for hypercholesterolemia and/or hypertriglyceridemia |
| 02/02/2006 | WO2006011479A1 Processes for producing cellooligosaccharide |
| 02/02/2006 | WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | WO2006011148A2 Novel crystalline forms of 6alpha, 9alpha-difluoro-11beta hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxy-androsta-1,4-diene-17beta-carboxylic acid and processes for preparation thereof |
| 02/02/2006 | WO2006011130A1 Adenosine a3 receptor agonists for the treatment of dry eye disorders including sjogren’s syndrome |
| 02/02/2006 | WO2006011050A2 Pyridine derivatives |
| 02/02/2006 | WO2006011046A1 Formulation for stimulating hair growth |
| 02/02/2006 | WO2006011007A1 Combination anticancer therapy and pharmaceutical compositions therefore |
| 02/02/2006 | WO2006010968A1 New aryloxy acetic acid amide derivatives |
| 02/02/2006 | WO2006010915A1 Substituted triazines as prion protein ligands and their use to detect or remove prions |
| 02/02/2006 | WO2006010868A1 Pharmaceutical formulation based on antibiotic in microcapsule form |
| 02/02/2006 | WO2006010859A1 Novel angiogenesis inhibitors and pharmaceutical and cosmetic use thereof |
| 02/02/2006 | WO2006010838A2 Products containing at least one anticancer active principle with low diffusion and an immunostimulatory active principle |
| 02/02/2006 | WO2006010775A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/02/2006 | WO2006010767A1 Veterinary composition comprising an arylpyrazole and a nitroenamine with enhanced antiparasitic activity |
| 02/02/2006 | WO2006010756A1 Oxazolidinone compounds and compositions and methods related thereto |
| 02/02/2006 | WO2006010750A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 02/02/2006 | WO2006010748A1 Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate |
| 02/02/2006 | WO2006010653A1 New polymorphous form of rosiglitazone maleate |
| 02/02/2006 | WO2006010643A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/02/2006 | WO2006010620A2 Olanzapine salts and their conversion to olanzapine free base |
| 02/02/2006 | WO2006010598A1 Non-glycosidic and non-peptidic select inhibitors, and the use thereof |
| 02/02/2006 | WO2006010591A2 Quinazoline derivatives |
| 02/02/2006 | WO2006010587A1 Use of compounds active on the sigma receptor for the treatment of mechanical allodynia |
| 02/02/2006 | WO2006010577A1 Substituted 3-phenylpiperidine derivatives |
| 02/02/2006 | WO2006010560A2 Physiologically active composition |
| 02/02/2006 | WO2006010546A2 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 02/02/2006 | WO2006010504A1 Rxr antagonist treatment against multiple sclerosis |
| 02/02/2006 | WO2006010503A2 Rxr antagonists in the treatment of inflammatory diseases |
| 02/02/2006 | WO2006010445A1 Trpv1 agonists, formulations containing them and uses thereof |
| 02/02/2006 | WO2006010422A1 Guanidine derivatives and therapeutic uses thereof |
| 02/02/2006 | WO2006010362A1 Amino adamantane derivatives, methods for the production and use thereof |
| 02/02/2006 | WO2006010283A1 Prevention and treatment of thrombus formation |
| 02/02/2006 | WO2005123772A3 Anti-cancer therapy |
| 02/02/2006 | WO2005123130A3 Improved treatments of rheumatic and arthritic diseases comprising combinations of a 5-lipoxygenase inhibitor |
| 02/02/2006 | WO2005123086A3 Ziprasidone dosage form |
| 02/02/2006 | WO2005118541A3 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/02/2006 | WO2005117846A3 Ice inhibitors for the treatment of autoinflammatory diseases |
| 02/02/2006 | WO2005115996B1 Sulfamic acid ester compounds useful in the inhibition of seroid sulphatase activity and aromatase activity |
| 02/02/2006 | WO2005115472A3 Compositions comprising gamma-linolenic acid and iodine for improving breast health in women |
| 02/02/2006 | WO2005115392A3 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 02/02/2006 | WO2005113511A9 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/02/2006 | WO2005112929A3 Anti-hiv-1 activity of betulinol derivatives |
| 02/02/2006 | WO2005112903A3 Use of ghrelin antagonists for improving cognition and memory |
| 02/02/2006 | WO2005111056B1 New esters of adenosine nucleosides and carboxylic acid |
| 02/02/2006 | WO2005107874A3 Use of pirinixinic acid and the salts thereof for treating chronic inflammatory diseases |